CFTR regulates B cell activation and lymphoid follicle development
Author
Polverino, FrancescaLu, Bao
Quintero, Joselyn Rojas
Vargas, Sara O
Patel, Avignat S
Owen, Caroline A
Gerard, Norma P
Gerard, Craig
Cernadas, Manuela
Affiliation
Univ Arizona, Asthma & Airway Dis Res CtrIssue Date
2019-07-01
Metadata
Show full item recordPublisher
BMCCitation
Polverino, F., Lu, B., Quintero, J. R., Vargas, S. O., Patel, A. S., Owen, C. A., ... & Cernadas, M. (2019). CFTR regulates B cell activation and lymphoid follicle development. Respiratory research, 20(1), 133.Journal
RESPIRATORY RESEARCHRights
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
The number of LFs, BAFF+, TLR4+ and proliferation marker Ki67+ B cells in lung explants or resections from subjects with CF and normal controls was quantified by immunostaining. The role of CFTR in B cell activation and LF development was then examined in two independent cohorts of uninfected CFTR-deficient mice (Cftr -/-) and wild type controls. The number of lung LFs, B cells and BAFF+, CXCR4+, immunoglobulin G+ B cells was examined by immunostaining. Lung and splenocyte B cell activation marker and major histocompatibility complex class II (MHC class II) expression was quantified by flow cytometry. Inflammatory cytokine levels were measured in supernatants from isolated B cells from Cftr -/- and wild type mice stimulated in vitro with Pseudomonas aeruginosa lipopolysaccharide (LPS).Note
Open access journalISSN
1465-993XEISSN
1465-9921PubMed ID
31262295Version
Final published versionSponsors
CT/MA Cystic Fibrosis/Multiple Sclerosis Fund; May Family Trust; CF Foundation [DRUMMR0, DRUMMR1]ae974a485f413a2113503eed53cd6c53
10.1186/s12931-019-1103-1
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Related articles
- Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
- Authors: Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A, Weber PP, Colledge WH, Evans MJ, Geddes DM, Alton EW
- Issue date: 2001 Jan
- B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.
- Authors: Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, Pinto-Plata V, Sholl L, Rosas IO, Agustí A, Celli BR, Owen CA
- Issue date: 2015 Sep 15
- Lung arginase expression and activity is increased in cystic fibrosis mouse models.
- Authors: Jaecklin T, Duerr J, Huang H, Rafii M, Bear CE, Ratjen F, Pencharz P, Kavanagh BP, Mall MA, Grasemann H
- Issue date: 2014 Aug 1
- Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
- Authors: Bodas M, Mazur S, Min T, Vij N
- Issue date: 2018 Jan 4
- Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
- Authors: Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB
- Issue date: 2001 Jun 15